Abstract
Purpose
The asbestos-related problems caused much social concern; however, no large-scale study was conducted about clinical features of MM in Japan. Patients with MM who have a history of occupational asbestos exposure (AE) are provided worker’s compensation in Japan. However, only about 10% of MM cases were actually claimed and compensated. So there is still controversy over the association between MM and AE. The aim of this study is to investigate the clinical features of MM. We also aimed to clarify the association between MM and occupational AE in Japan.
Methods
We examined the clinical features of MM cases. Clinical information was obtained including gender, age, site of origin, pathological subtype, radiological findings, and treatment outcome. To investigate the association between MM and AE, investigators interviewed all patients regarding work and residential history.
Results
Between January 2005 and December 2007, 105 cases (median age: 63 years, range 35–80, male/female: 88/17) were diagnosed with MM in the Rosai Hospital group and related facilities. Among them, 94(89.5%) cases originated in the pleura, 7(6.7%) in the peritoneum, 2(1.9%) in the pericardium, and 1(0.9%) in the tunica vaginalis testis. There were 69(65.7%) epithelioid, 19(18.1%) biphasic, 16(15.2%) sarcomatoid, and 1 unclassified pathological subtypes of MM. A favorable survival rate was indicated in the patient group of MPM that underwent surgery compared to others, though it was not statistically significant (P = 0.1743). The occupational AE was indicated in 89 cases (84.8%). Three patients had no history of occupational AE, but lived with someone who was in an occupation that handled asbestos. There were two patients in which AE was indicated in their life environment. Altogether, AE was indicated in 93(88.6%) patients.
Conclusions
This study stresses the urgent need for physicians to acknowledge the association between MM and AE, and to inquire thoroughly regarding AE to the patients with MM.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aleman C, Sanchez L, Alegre J, Ruiz E, Vazquez A, Soriano T, Sarrapio J, Teixidor J, Andreu J, Felip E, Armadans L, Fernandez De Sevilla T (2007) Differentiating between malignant and idiopathic pleural effusions: the value of diagnostic procedures. Qjm 100:351–359
Castagneto B, Botta M, Aitini E, Spigno F, Degiovanni D, Alabiso O, Serra M, Muzio A, Carbone R, Buosi R, Galbusera V, Piccolini E, Giaretto L, Rebella L, Mencoboni M (2008) Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM). Ann Oncol 19:370–373
Kishimoto T, Ozaki S, Kato K, Nishi H, Genba K (2004) Malignant pleural mesothelioma in parts of Japan in relationship to asbestos exposure. Ind Health 42:435–439
Kushitani K, Takeshima Y, Amatya VJ, Furonaka O, Sakatani A, Inai K (2008) Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry. Pathol Int 58:75–83
Magnani C, Agudo A, Gonzalez CA, Andrion A, Calleja A, Chellini E, Dalmasso P, Escolar A, Hernandez S, Ivaldi C, Mirabelli D, Ramirez J, Turuguet D, Usel M, Terracini B (2000) Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos. Br J Cancer 83:104–111
Newhouse ML, Thompson H (1965) Mesothelioma of pleura and peritoneum following exposure to asbestos in the London area. Br J Ind Med 22:261–269
Ohshima H (2005) Five cases with mesothelioma living near a now-defunct asbestos cement plant in Amagasaki city (in Japanese). In Mainichi newspaper pp 1(June 29)
Rees D, Myers JE, Goodman K, Fourie E, Blignaut C, Chapman R, Bachmann MO (1999) Case-control study of mesothelioma in South Africa. Am J Ind Med 35:213–222
Robinson BW, Lake RA (2005) Advances in malignant mesothelioma. N Engl J Med 353:1591–1603
Rusch VW (1996) A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group. Lung Cancer 14:1–12
Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, DeCamp MM Jr, Swanson SJ, Bueno R, Lukanich JM, Baldini EH, Mentzer SJ (1999) Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117:54–63 (Discussion 63–5)
Takeshima Y, Inai K, Amatya VJ, Gemba K, Aoe K, Fujimoto N, Kato K, Kishimoto T (2009) Accuracy of pathological diagnosis of mesothelioma cases in Japan: Clinicopathological analysis of 382 cases. Lung Cancer 66:191–197
Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21:2636–2644
Wagner JC, Sleggs CA, Marchand P (1960) Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 17:260–271
Acknowledgments
This research is a part of the research and development and dissemination projects related to the 13 fields of occupational injuries and illnesses of the Japan Labour Health and Welfare Organization.
Conflict of interest statement
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Dr. K. Yamazaki passed away in 2008.
Rights and permissions
About this article
Cite this article
Fujimoto, N., Aoe, K., Gemba, K. et al. Clinical investigation of malignant mesothelioma in Japan. J Cancer Res Clin Oncol 136, 1755–1759 (2010). https://doi.org/10.1007/s00432-010-0834-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-010-0834-7